5 Clinical Trials Found
Drug: JAB-21822 Monotherapy
Indication: NSCLC, PDAC, CRC, Other advanced solid tumors
Region: US, Europe
Drug: JAB-8263 Monotherapy
Indication: BRD-NUT, Prostate cancer, Other advanced solid tumors
Region: US
Drug: JAB-BX102 Monotherapy
Indication: Thyroid cancer, ACC, Other advanced solid tumors
Region: China, US
Drug: JAB-2485 Monotherapy
Indication: TNBC, SCLC, ER+Breast Cancer, Other advanced solid tumors
Region: China, US

Platform & Pipeline

Partnership